Cargando…
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
The targeting of glutamine metabolism specifically via pharmacological inhibition of glutaminase 1 (GLS1) has been translated into clinical trials as a novel therapy for several cancers. The results, though encouraging, show room for improvement in terms of tumor reduction. In this study, the glutam...
Autores principales: | Udupa, Sunag, Nguyen, Stephanie, Hoang, Giang, Nguyen, Tu, Quinones, Addison, Pham, Khoa, Asaka, Ryoichi, Nguyen, Kiet, Zhang, Cissy, Elgogary, Amira, Jung, Jin G., Xu, Qingguo, Fu, Jie, Thomas, Ajit G., Tsukamoto, Takashi, Hanes, Justin, Slusher, Barbara S., Cooper, Arthur J. L., Le, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851409/ https://www.ncbi.nlm.nih.gov/pubmed/31231915 http://dx.doi.org/10.1002/pmic.201800451 |
Ejemplares similares
-
Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020) -
Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer
por: Nguyen, Tu, et al.
Publicado: (2019) -
Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane
Scaffold
por: Zimmermann, Sarah C., et al.
Publicado: (2016) -
Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015) -
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)